The in vivo antitumor effects of RGR-TRAIL and TRAIL were further evaluated in mice bearing tumor xenografts of either COLO205, LS174T, HCT116 or HT29 CRC cells. The gene discussed is TNFSF10; the disease is colorectal carcinoma.